• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耶尔森氏菌V抗原以涉及白细胞介素-10的方式诱导Toll样受体(TLR)的同型和异型耐受。

Yersinia V antigen induces both TLR homo- and heterotolerance in an IL-10-involving manner.

作者信息

Reithmeier-Rost Dagmar, Bierschenk Suse, Filippova Natalia, Schröder-Braunstein Jutta, Sing Andreas

机构信息

Max von Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie, Ludwig-Maximilians-Universität München, Pettenkoferstrasse 9a, 80336 München, Germany.

出版信息

Cell Immunol. 2004 Sep-Oct;231(1-2):63-74. doi: 10.1016/j.cellimm.2004.12.003. Epub 2005 Jan 7.

DOI:10.1016/j.cellimm.2004.12.003
PMID:15919371
Abstract

The virulence antigen (LcrV) of pathogenic yersiniae "silences" macrophages against stimulation with the TLR2-agonist zymosan A in a CD14/TLR2-dependent fashion via IL-10 induction. This pathogenically important "silencing" resembles TLR tolerance phenomena; in these, pre-exposure to a primary tolerizing TLR-agonist renders macrophages unresponsive to stimulation with a secondary challenging TLR-agonist which may involve either the same (TLR homotolerance) or a different TLR (TLR heterotolerance) as the primary TLR-agonist. Here, we show that rLcrV induces TLR homo- and heterotolerance against TLR2- or TLR4-agonists both in human and murine macrophages, respectively. The underlying mechanism of LcrV-induced tolerance is most likely not due to changes in TLR2- or TLR4 expression, but involves LcrV-mediated IL-10 production, since LcrV-induced TLR homo- and heterotolerance is highly impaired in IL-10(-/-) macrophages. Moreover, the involvement of IL-10 in TLR tolerance induction seems to be a more general phenomenon as shown by experiments using different TLR-agonists in IL-10(-/-) macrophages. Since LcrV acts as a secreted protein upon macrophages without requiring direct cell contact, as shown in transwell assays, we propose that yersiniae exploit IL-10-involving TLR tolerance mechanisms by the virulence factor LcrV.

摘要

致病性耶尔森菌的毒力抗原(LcrV)通过诱导白细胞介素-10,以CD14/TLR2依赖的方式“沉默”巨噬细胞,使其对TLR2激动剂酵母聚糖A的刺激无反应。这种在致病方面很重要的“沉默”类似于TLR耐受现象;在这些现象中,预先接触一种主要的耐受诱导性TLR激动剂会使巨噬细胞对第二种具有挑战性的TLR激动剂的刺激无反应,这第二种激动剂可能与第一种TLR激动剂相同(TLR同型耐受)或不同(TLR异型耐受)。在此,我们表明重组LcrV分别在人和鼠巨噬细胞中诱导对TLR2或TLR4激动剂的TLR同型和异型耐受。LcrV诱导耐受的潜在机制很可能不是由于TLR2或TLR4表达的变化,而是涉及LcrV介导的白细胞介素-10的产生,因为在白细胞介素-10基因敲除(IL-10-/-)的巨噬细胞中,LcrV诱导的TLR同型和异型耐受受到严重损害。此外,如在IL-10-/-巨噬细胞中使用不同TLR激动剂的实验所示,白细胞介素-10参与TLR耐受诱导似乎是一种更普遍的现象。由于如在transwell实验中所示,LcrV作为一种分泌蛋白作用于巨噬细胞,无需直接细胞接触,我们提出耶尔森菌通过毒力因子LcrV利用涉及白细胞介素-10的TLR耐受机制。

相似文献

1
Yersinia V antigen induces both TLR homo- and heterotolerance in an IL-10-involving manner.耶尔森氏菌V抗原以涉及白细胞介素-10的方式诱导Toll样受体(TLR)的同型和异型耐受。
Cell Immunol. 2004 Sep-Oct;231(1-2):63-74. doi: 10.1016/j.cellimm.2004.12.003. Epub 2005 Jan 7.
2
Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model.Toll样受体2和4在口腔小肠结肠炎耶尔森菌小鼠感染模型中的作用。
Int J Med Microbiol. 2003 Nov;293(5):341-8. doi: 10.1078/1438-4221-00277.
3
Effect of rLcrV and rYopB from Yersinia pestis on murine peritoneal macrophages in vitro.
Immunol Lett. 2004 May 15;93(2-3):179-87. doi: 10.1016/j.imlet.2004.03.010.
4
Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor.来自鼠疫耶尔森菌的LcrV在双结合位点与人TLR-2和人IFN-γ受体的结合
J Proteome Res. 2007 Jun;6(6):2222-31. doi: 10.1021/pr070036r. Epub 2007 Apr 19.
5
The innate immune response to Entamoeba histolytica lipopeptidophosphoglycan is mediated by toll-like receptors 2 and 4.对溶组织内阿米巴脂肽磷壁酸聚糖的天然免疫反应由Toll样受体2和4介导。
Parasite Immunol. 2005 Apr;27(4):127-37. doi: 10.1111/j.1365-3024.2005.00754.x.
6
A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence.耶尔森菌LcrV的高变N端区域决定了Toll样受体2介导的IL-10诱导及小鼠毒力。
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16049-54. doi: 10.1073/pnas.0504728102. Epub 2005 Oct 20.
7
Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.脓毒症相关抗原刺激下Toll样受体(TLR)2和TLR4对CD14dimCD16+单核细胞的调控
Clin Exp Immunol. 2005 Aug;141(2):270-8. doi: 10.1111/j.1365-2249.2005.02839.x.
8
The induction of Toll-like receptor tolerance enhances rather than suppresses HIV-1 gene expression in transgenic mice.Toll样受体耐受性的诱导增强而非抑制转基因小鼠中的HIV-1基因表达。
J Leukoc Biol. 2004 Mar;75(3):460-6. doi: 10.1189/jlb.0803388. Epub 2003 Dec 4.
9
Yersinia-triggered arthritis in IL-12p40-deficient mice: relevant antigens and local expression of Toll-like receptor mRNA.白细胞介素-12 p40缺陷小鼠中耶尔森菌引发的关节炎:相关抗原及Toll样受体mRNA的局部表达
Scand J Rheumatol. 2007 Jan-Feb;36(1):28-35. doi: 10.1080/03009740600906651.
10
Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction.烟曲霉在萌发过程中通过丧失Toll样受体4介导的信号转导来逃避免疫识别。
J Infect Dis. 2003 Jul 15;188(2):320-6. doi: 10.1086/376456. Epub 2003 Jul 1.

引用本文的文献

1
Nanolipoprotein particle (NLP) vaccine confers protection against aerosol challenge in a BALB/c mouse model.纳米脂蛋白颗粒(NLP)疫苗在BALB/c小鼠模型中可提供针对气溶胶攻击的保护作用。
Front Immunol. 2025 Jun 26;16:1603710. doi: 10.3389/fimmu.2025.1603710. eCollection 2025.
2
Target the Host, Kill the Bug; Targeting Host Respiratory Immunosuppressive Responses as a Novel Strategy to Improve Bacterial Clearance During Lung Infection.靶向宿主,消灭细菌;针对宿主呼吸免疫抑制应答作为一种新策略改善肺部感染期间的细菌清除。
Front Immunol. 2020 Apr 30;11:767. doi: 10.3389/fimmu.2020.00767. eCollection 2020.
3
Lipopolysaccharide-primed heterotolerant dendritic cells suppress experimental autoimmune uveoretinitis by multiple mechanisms.
脂多糖预刺激的异源耐受性树突状细胞通过多种机制抑制实验性自身免疫性葡萄膜视网膜炎。
Immunology. 2017 Mar;150(3):364-377. doi: 10.1111/imm.12691. Epub 2016 Dec 18.
4
Plague Vaccines: Status and Future.鼠疫疫苗:现状与未来
Adv Exp Med Biol. 2016;918:313-360. doi: 10.1007/978-94-024-0890-4_12.
5
Aeromonas salmonicida subsp. salmonicida in the light of its type-three secretion system.基于其三型分泌系统的杀鲑气单胞菌杀鲑亚种
Microb Biotechnol. 2014 Sep;7(5):381-400. doi: 10.1111/1751-7915.12091. Epub 2013 Oct 7.
6
Amino acid substitutions in LcrV at putative sites of interaction with Toll-like receptor 2 do not affect the virulence of Yersinia pestis.LcrV 中与 Toll 样受体 2 相互作用的假定位点的氨基酸替换不影响鼠疫耶尔森菌的毒力。
Microb Pathog. 2012 Nov-Dec;53(5-6):198-206. doi: 10.1016/j.micpath.2012.07.003. Epub 2012 Jul 24.
7
Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens.白细胞介素-10 与针对原核和真核细胞内病原体的免疫。
Infect Immun. 2011 Aug;79(8):2964-73. doi: 10.1128/IAI.00047-11. Epub 2011 May 16.
8
Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge.评价经减毒鼠伤寒沙门氏菌传递给小鼠的 Psn、HmuR 和改良 LcrV 蛋白作为抗鼠疫菌巴氏亚种和肺鼠疫亚种感染的疫苗。
Vaccine. 2010 Dec 16;29(2):274-82. doi: 10.1016/j.vaccine.2010.10.033. Epub 2010 Oct 24.
9
Amino acid and structural variability of Yersinia pestis LcrV protein.鼠疫耶尔森氏菌 LcrV 蛋白的氨基酸和结构变异性。
Infect Genet Evol. 2010 Jan;10(1):137-45. doi: 10.1016/j.meegid.2009.10.003. Epub 2009 Oct 14.
10
Oral vaccination with LcrV from Yersinia pestis KIM delivered by live attenuated Salmonella enterica serovar Typhimurium elicits a protective immune response against challenge with Yersinia pseudotuberculosis and Yersinia enterocolitica.用减毒活鼠伤寒沙门氏菌携带的鼠疫杆菌KIM株的LcrV进行口服疫苗接种,可引发针对假结核耶尔森菌和小肠结肠炎耶尔森菌攻击的保护性免疫反应。
Vaccine. 2009 Aug 27;27(39):5363-70. doi: 10.1016/j.vaccine.2009.06.078. Epub 2009 Jul 9.